Allergan Sues FDA over Ban on Off-Label Marketing of Botox

[guest]

The drugmaker's unprecedented lawsuit contends that the FDA's ban on off-label marketing violates the company's free speech rights


More...

Toggle signature
||||| Mentor Group Access Now! |||||